Confronting the pneumococcus: A target shift or bullet change?

Vaccine

Volumn 19, Issue 9-10, 2000, Pages 1211-1217

  Obaro, Steven K ^a  

^a MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

Author keywords

Bacteria; Diesease; Streptococcus pneumoniae; Vaccine

Indexed keywords

ARTICLE; DRUG EFFICACY; IMMUNITY; IMMUNOGENICITY; MEDICAL RESEARCH; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

EID: 0034623974     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(00)00262-0     Document Type: Note

References (42)

1. Prevention of pneumococcal disease: Recommendation of the Advisory Committee on Immunization Practices (ACIP)
2. The epidemiology of pneumococcal disease in infants and children
3. Bacterial meningitis in the United States, report of a multistate surveillance study, 1986
4. Acute respiratory infections are the leading cause of death in children in developing countries
5. Efficacy, safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in children
6. Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate vaccine for prevention of pneumonia and meningitis in Gambian infants
7. Community-acquired pneumonia in adults in British hospitals 1982-1983: A survey of aetiology, mortality, prognostic factors and outcome
8. Polysaccharide-protein conjugates: A new generation of vaccines
9. Immunologic priming of young children by pneuococcal glycoprotien conjugate, but not polysaccharide vaccines
10. A glycoprotein pneumococcal conjugate vaccine primes for antibody responses to a pneumococcal polysaccharide vaccine in Gambian children
11. Pneumococcal disease among children in rural west Africa
12. The pneumococcal problem: A review
13. Anti-pneumococcal antibody response in normal subjects: A meta-analysis
14. Defective antibody-mediated opsonisation of S. pneumoniae in high risk patients determined by flow cytometry
15. Standardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells
16. Avidity as a determinant of the protective efficacy of human antibodies to pneumococcal capsular polysaccharides
17. Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity
18. Truncated Streptococcus pneumoniae PspA molecules elicit protective immunity against fatal pneumococcal challenge in mice
19. Protection of mice against fatal pneumococcal challenge by immunization with pneumococcal surface adhesin A (PsaA)
20. Immunization of mice with pneumolysin toxoid confers a significant degree of protection against at least nine serotypes of Streptococcus pneumoniae
21. Intranasal immunization of mice with PspA (pneumococcal surface protein A) can prevent intranasal carriage, pulmonary infection and sepsis with Streptococcus pneumoniae
22. Effect of defined point mutations in the pneumolysin gene on the virulence of Streptococcus pneumoniae
23. Effect of insertional inactivation of the genes encoding pneumolysin and autolysin on the virulence of Streptococcus pneumoniae type 3
24. Sytemic and mucosal protective immunity to pneumococcal surface protein A
25. Limited diversity of Streptococcus pneumoniae psaA among pneumococcal vaccine serotypes
26. Comparative efficacy of pneumococcal neuraminidase and pneumolysin as immunogens protective against infection by Streptococcus pneumoniae
27. Comparative efficacy of autolysin and pneumolysin as immunogens protecting mice against infection by Streptococus pneumoniae
28. Contribution of a novel choline binding protein to adherence, colonization and immunogenicity of Streptococcus pneumoniae
29. Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine
30. Carriageof pneumococci after pneumococcal vaccination
31. Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine
32. Antibody persistence and Haemophilus influenzae type b carriage after infant immunization with PRP-T
33. Effect of a heptavalent pneumococcal conjugate vaccine on pneumococcal acute otitis media by serotype
34. Establishment of a Streptococcus pneumoniae nasopharyngeal colonization model in adult mice
35. Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor
36. Effect of xylitol on growth of nasopharygeal bacteria in vitro
37. Xylitol chewing gum in prevention of acute otitis media: Double blind randomised trial
38. Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae
39. Possible relationship of pneumococcal surface adhesin A antibody level to nasopharyngeal carriage of Streptococcus pneumoniae in young African infants
40. Anti-polysaccharide immunoglobulin isotype levels and opsonic activity of antisera: Relationships with protection against Streptococcus pneumoniae infection in mice
41. Progress on development of live BCG recombinant vaccine for combined vaccine delivery